Collectively, our research indicates that Rb1 exerts antidepressant-like effects in a mouse model of CUMS-induced depression by promoting BDNF signaling, thus providing new insights into the pharmacological effects of Rb1 in the treatment of depression. Here, BDNF is linked to depressive symptom measurement.